NVAX
NASDAQ · Biotechnology
Novavax Inc
$9.13
-0.37 (-3.89%)
Analyst Consensus
Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+216.3% upside
Low Target
$20.35
Average Target
$28.88
High Target
$29.25
Current Price
$9.13
Current
$9.13
$9.13
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Scenario Analysis
Bear Case
$20.35
122.9%
Low target
Base Case
$28.88
+216.3%
Avg target
Bull Case
$29.25
+220.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$11.97
-23.7% from high
52-Week Low
$6.13
+48.9% from low
Target vs 52W High
$28.88
+141.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +9.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.0% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +190.0% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -6.4% |
| REGN | Buy | 38 | 71% | $76.80 | -87.6% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -64.5% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.7% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -39.1% |